- Coordinator
- Uab Inovatyvi Medicina, Lithuania
- Runs
- 1 May 2022 to 31 July 2024
- Status
- Finished
- EU funding
- €2.5m
- Total cost
- €3.6m
- Partners
- 1 organisations in 1 countries
- Type
- European Innovation Council
- Grant agreement
- 190123213
What the project is doing
In the project's own words, from its summary on CORDIS.
We have developed a smart, sensory, teleoperated robotic system for endovascular procedures – Sentante. It allows an endovascular procedure to be performed without exposure to harmful X-rays. Using a robotic system doctors may perform the full endovascular procedure from a different room, in the future – even a different hospital. Intuitive controls and universal compatibility with marketed endovascular instruments make Sentante ideal for fast implementation into the routine clinical workflow with almost no additional training.
Patients will benefit from better treatment availability, particularly in urgent cases with no need for patient transportation from a local hospital. Hospitals will benefit from cheaper 24/7 service, the ability to retain experienced doctors, attract more patients. AI implementation and partial automatization of some of the procedures are planned for the future.
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Uab Inovatyvi Medicina | Kaunas | Lithuania | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI